re: Ann: 18.7 Per Cent Dose Sales Growth for ... Yes indeed, GW has been very careful with SH funds, and has resisted expansion by buying other businesses. However that does create a one horse pony, until some of the R&D comes home.
Also helps that they have been profitable for some years now.
Ann: 18.7 Per Cent Dose Sales Growth for 2nd Quar, page-13
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $80.64M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 19.0¢ | $289.9K | 1.524M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 45930 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 504000 | 3 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |